← All indications
Pulmonary Arterial Hypertension
A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.
Drugs by status
Approved for this indication (9)
Phase 4 trials (10)
Phase 3 trials (15)
Phase 2 trials (43)
- sodium nitrite
- zamicastat
- capsaicin
- bardoxolone
- Cicletanine
- cxa-10
- dehydroepiandrosterone
- valproic acid
- empagliflozin
- fulvestrant
- ferric carboxymaltose
- tacrolimus
- famotidine
- xenon-129
- jtt-251
- fluoxetine
- pb1046
- selonsertib
- valsartan
- qcc374
- sitagliptin
- intepirdine
- sulfasalazine
- tezosentan
- anastrozole
- tocilizumab
- ubenimex
- 2-hoba
- apabetalone
- carvedilol
- +13 more
Phase 1 trials (24)